We Are #MightyTogether

Create a new post for topic
Join the Conversation on
We Are #MightyTogether
213K people
0 stories
51.8K posts
About We Are #MightyTogether Show topic details
Explore Our Newsletters
What's New in We Are #MightyTogether
All
Stories
Posts
Videos
Latest
Trending
Post

New Studies: BTK Inhibitor

A BTK inhibitor is an experimental therapy that blocks Bruton’s tyrosine kinase (BTK). BTK is an enzyme that activates certain immune cells that play a major role in the response that damages the brain and spinal cord in multiple sclerosis. It’s taken by mouth as a tablet. Read all about BTK inhibitors.

Two new studies are recruiting people with primary progressive or secondary progressive MS, testing the effectiveness of orelabrutinib, a BTK inhibitor. Click the links above to find out more about these studies and recruiting locations.

More info on primary progressive study: www.nationalmssociety.org/how-you-can-help/get-involved/part...

More info on secondary progressive study: www.nationalmssociety.org/how-you-can-help/get-involved/part...

#MultipleSclerosis #MightyTogether

Empowering people affected by MS to live their best lives

The National Multiple Sclerosis Society exists because there are people with MS. Our vision is a world free of MS.